Prognosis in monoclonal gammopathy of undetermined significance

British Journal of Haematology

Volumn 97, Issue 3, 1997, Pages 649-651

  Vuckovic, Josko ^a,d   Ilic, Anita ^b   Knezevic, Nebojsa ^b   Marinkovic, Marija ^b   Zemunik, Tatijana ^c   Dubravcic, Mirko ^b  

^a Inst of Social Sciences Ivo Pilar   (Croatia)

^b UNIVERSITY HOSPITAL SPLIT   (Croatia)

^c UNIVERSITY OF SPLIT   (Croatia)

^d University of Zagreb   (Croatia)

Author keywords

malignant transformation; monoclonal gammopathy of undetermined significance; prognosis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL;

EID: 0030949549     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.1072923.x     Document Type: Article

References (10)

1. Axelsson, U. (1986) A 20-year follow-up study of 64 subjects with M-components. Acta Medica Scandinavica, 219, 519-522.
2. Blade, J., Guillermo, A.L., Rozman, C., Cervantes, F., Salgado, C., Aquilar, J.L., Vives-Corrons, J.L. & Montserrat, E. (1992) Malignant transformation and life expectancy in monoclonal gammopathy of undetermined significance. British Journal of Haematology, 81, 391-394.
3. Carter, A. & Tatarsky, I. (1980) The physiopathological significance of benign monoclonal gammopathy: a study of 64 cases. British Journal of Haematology, 46, 565-574.
4. Greipp, P.R. & Kyle, R.A. (1983) Clinical morphological and cell kinetic differences among multiple myeloma, monoclonal gammopathy of undetermined significance, and smoldering multiple myeloma. Blood, 62, 166-171.
5. Hobbs, J.R. (1971) Immunocytoma o'mice an'men. British Medical Journal, ii, 67-72.
6. Kaplan, E.L. & Meier, P. (1958) Non-parametric estimation from incomplete observations. Journal of the American Statistical Association, 53, 457-481.
7. Kyle, R.A. (1978) Monoclonal gammopathy of undetermined significance: natural history in 241 cases. American Journal of Medicine, 64, 814-826.
8. Kyle, R.A. (1992) Diagnostic criteria of multiple myeloma. Hematology/Oncology Clinics of North America, 6, 547-358.
9. Moller-Petersen, J. & Schmidt, E.B. (1986) Diagnostic value of the concentration of M-component in initial classification of monoclonal gammopathy. Scandinavian Journal of Haematology, 36, 295-301.
10. Ritzmann, S.E., Loukas, D., Sakai, H., Daniels, J.C. & Lewin, W.C. (1975) Idiopathic (asymptomatic) monoclonal gammopathies. Archives of Internal Medicine, 135, 95-106.